Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier BV in Schizophrenia Research
- Vol. 66 (2-3), 101-113
- https://doi.org/10.1016/j.schres.2003.07.009
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160???mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) studyInternational Clinical Psychopharmacology, 2002
- Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective DisorderAmerican Journal of Psychiatry, 2002
- Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical CorrelatesAmerican Journal of Psychiatry, 2000
- Cognitive and behavioral precursors of schizophreniaDevelopment and Psychopathology, 1999
- Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder A 6-Week Placebo-Controlled TrialNeuropsychopharmacology, 1999
- Dopamine in schizophrenia: a review and reconceptualizationAmerican Journal of Psychiatry, 1991
- Cognitive functioning and positive and negative symptoms in schizophreniaSchizophrenia Research, 1991
- Neuroleptic drug effects on cognitive function in schizophreniaSchizophrenia Research, 1990
- The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patientsPsychiatry Research, 1989
- Anticholinergic Effects on MemoryJournal of Clinical Psychopharmacology, 1989